Table 1 RFID Localizer 1 Trial patient eligibility

Inclusion criteria

Female patient ≥ 18 years of age

Patient has a nonpalpable histologically proven in situ or invasive breast cancer that is visible on ultrasound

Patient is scheduled for breast conserving surgery

Exclusion criteria

Lesion depth > 7 cm in supine position

Patient has multicentric breast cancer

Patient is pregnant or lactating

Patient is unable to understand and sign the study specific informed consent form after the nature of the study has been fully explained

Patient will undergo neoadjuvant treatment^a